BRIEF-Allergan announces FDA approval of RHOFADE cream
January 19, 2017 at 08:18 AM EST
* Allergan announces FDA approval of RHOFADE (oxymetazoline hydrochloride) cream, 1% for the topical treatment of persistent facial Erythema associated with Rosacea in adults
